DEVELOPMENT AND VALIDATION OF INNOVATIVE CELL MODELS FOR PARKINSON’S DISEASE WITH HUMAN NEURONS DERIVED FROM REPROGRAMMED STEM CELLS FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIES DEVELOPMENT AND VALIDATION OF INNOVATIVE CELL MODELS FOR PARKINSON’S DISEASE WITH HUMAN NEURONS DERIVED FROM REPROGRAMMED STEM CELLS FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL INDUSTRIESshare on FacebookTwitterLinkedinEmailreport an issue